One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment
Objectives To identify and characterise a subgroup of patients with early rheumatoid arthritis (RA) reporting not feeling well 1 year after treatment initiation despite achieving optimal disease control according to current treatment standards.Methods This observational study included participants o...
Main Authors: | René Westhovens, An De Groef, Kristien Van der Elst, Philip Moons, Diederik De Cock, Sofia Pazmino, Veerle Stouten, Johan Joly, Patrick Verschueren, Johanna Vriezekolk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-05-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/6/1/e001146.full |
Similar Items
-
The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups
by: Michaël Doumen, et al.
Published: (2021-08-01) -
Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa
by: Christophe Mulumba, et al.
Published: (2019-09-01) -
Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
by: Marina Amaral de Ávila Machado, et al.
Published: (2016-01-01) -
Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors
by: Xue Han, et al.
Published: (2021-05-01) -
Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
by: Mahlich J, et al.
Published: (2016-08-01)